US2017112808A1PendingUtilityA1

Uses of compounds and mixtures from antrodia cinnamomea mycelia

44
Assignee: SIMPSON BIOTECH CO LTDPriority: Oct 23, 2013Filed: Jan 5, 2017Published: Apr 27, 2017
Est. expiryOct 23, 2033(~7.3 yrs left)· nominal 20-yr term from priority
A61P 9/00A61P 3/10A61P 29/00A61P 19/02A61P 17/02A61P 13/12A61P 17/16A61P 1/16A61P 11/00A61P 17/18A61P 17/00A61P 1/02A61K 31/34A61K 31/341A61K 8/4913A61K 8/4973A61K 31/4015A61K 2800/522A61Q 19/08A61K 2236/19A61Q 19/02A61K 8/9728A61K 36/07
44
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to novel uses of compounds from Antrodia cinnamomea mycelia and mixtures comprising the compounds. The novel uses comprise whitening skin, combating skin ageing, reducing scar formation, inducing or enhancing liver regeneration, or treating fibrosis or a fibrosis-associated disorder in a subject in need thereof. The compounds have the formula and preferably are selected from 3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]furan-2,5-dione, 3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]-1H-pyrrol-2,5-dione, 3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]-1H-pyrrol-1-ol-2,5-dione, 3R*,4S*-1-hydroxy-3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]pyrrolidine-2,5-dione, and 3R*,4R*-1-hydroxy-3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]pyrrolidine-2,5-dione.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for inducing or enhancing liver regeneration, comprising administering to a subject in need thereof an effective amount of a composition comprising a compound having the formula 
       
         
           
           
               
               
           
         
         or its tautomeric forms, its stereoisomers, its polymorphs, its salts, or its solvates, 
         wherein 
         X is N or O; 
         R 1  is H, hydroxyl, C 1-10  alkyloxy, C 2-10  alkenyloxy, or C 2-10  alkynyloxy; 
         R 2  is H, hydroxyl, C 1-10  alkyl, C 2-10  alkenyl or C 2-10  alkynyl; 
         R 3  is H, hydroxyl, C 1-10  alkyl, C 2-10  alkenyl or C 2-10  alkynyl; 
            denotes a single or double bond; 
         provided that 
         if X is O, R 3  is absent; 
         if   denotes a single bond, the compound has the formula: 
       
       
         
           
           
               
               
           
         
       
     
     
         2 . The method of  claim 1 , wherein the compound is
 3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]furan-2,5-dione,   3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]-1H-pyrrol-2,5-dione,   3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]-1H-pyrrol-1-ol-2,5-dione,   3R*,4S*-1-hydroxy-3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]pyrrolidine-2,5-dione, or   3R*,4R*-1-hydroxy-3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]pyrrolidine-2,5-dione.   
     
     
         3 . The method of  claim 1 , wherein the subject has a liver resection. 
     
     
         4 . The method of  claim 1 , wherein the subject has liver fibrosis or cirrhosis. 
     
     
         5 . A method for inducing or enhancing liver regeneration, comprising administering to a subject in need thereof an effective amount of a mixture comprising water or organic solvent extract of mycelium of  Antrodia cinnamomea , wherein the extract comprises a compound having the formula 
       
         
           
           
               
               
           
         
         or its tautomeric forms, its stereoisomers, its polymorphs, its salts, or its solvates, 
         wherein 
         X is N or O; 
         R 1  is H, hydroxyl, C 1-10  alkyloxy, C 2-10  alkenyloxy, or C 2-10  alkynyloxy; 
         R 2  is H, hydroxyl, C 1-10  alkyl, C 2-10  alkenyl or C 2-10  alkynyl; 
         R 3  is H, hydroxyl, C 1-10  alkyl, C 2-10  alkenyl or C 2-10  alkynyl; 
            denotes a single or double bond; 
         provided that 
         if X is O, R 3  is absent; 
         if   denotes a single bond, the compound has the formula: 
       
       
         
           
           
               
               
           
         
       
     
     
         6 . The method of  claim 5 , wherein the compound is
 3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]furan-2,5-dione,   3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]-1H-pyrrol-2,5-dione,   3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]-1H-pyrrol-1-ol-2,5-dione,   3R*,4S*-1-hydroxy-3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]pyrrolidine-2,5-dione, or   3R*,4R*-1-hydroxy-3-isobutyl-4-[4-(3-methyl-2-butenyloxy)phenyl]pyrrolidine-2,5-dione.   
     
     
         7 . The method of  claim 5 , wherein the fermented mycelium of  Antrodia cinnamomea  is prepared by submerged liquid fermentation. 
     
     
         8 . The method of  claim 5 , wherein the organic solvent comprises but is not limited to alcohol, ester, alkane, and halogenated alkane. 
     
     
         9 . The method of  claim 8 , wherein the organic solvent is ethanol or alcoholic solvent. 
     
     
         10 . The method of  claim 5 , wherein the subject has a liver resection. 
     
     
         11 . The method of  claim 5 , wherein the subject has liver fibrosis or cirrhosis.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.